Skip to content
Pharmacy (PhLE)

Clinical Pharmacy

"Future RPh! Clinical Pharmacy is about patient-centered care. Hindi lang tayo nagbibigay ng gamot - tayo ang drug experts na nagpapayo sa doctors at nurses para sa safe and effective medication use. Laban lang, future clinical pharmacist!"

1. Introduction to Clinical Pharmacy 🏥

Clinical pharmacy focuses on the patient-centered approach to medication management. As a clinical pharmacist, you work directly with healthcare teams to optimize drug therapy outcomes.

Key Responsibilities of a Clinical Pharmacist:

  • Drug therapy monitoring and optimization
  • Patient counseling and medication education
  • Drug information services to healthcare professionals
  • Participation in medical rounds and case conferences
  • Adverse drug reaction monitoring and reporting
  • Development of formulary and drug use policies

Remember: Clinical pharmacy transforms the role of pharmacists from dispensing professionals to integral members of the healthcare team. Sa hospital setting, ikaw ang expert sa medications!

2. Medication Therapy Management (MTM) 💊

MTM is a systematic approach to optimize drug therapy outcomes. It involves reviewing all medications, identifying problems, and creating action plans.

MTM Component Description Example Actions
Medication Therapy Review (MTR) Comprehensive assessment of all medications Check for duplications, interactions, appropriateness
Personal Medication Record (PMR) Complete list of patient's medications Document Rx, OTC, supplements, herbal products
Medication-Related Action Plan (MAP) Patient-specific plan to address issues Simplify regimen, address adherence barriers
Intervention and Referral Actions taken and follow-up care Contact physician, schedule follow-up
Documentation and Follow-up Record keeping and outcome monitoring Track progress, measure outcomes

💡 Board Exam Tip:

MTM is a billable service in many healthcare systems. Know the 5 core elements and how they apply to patient care scenarios in board exam questions!

3. Drug-Related Problems (DRPs) ⚠️

DRPs are events involving drug therapy that actually or potentially interfere with desired health outcomes. Identifying and resolving DRPs is the core of clinical pharmacy practice.

DRP Category Description Clinical Example
Unnecessary Drug Therapy No medical indication Antibiotics for viral infection
Needs Additional Therapy Untreated condition Diabetic without statin therapy
Ineffective Drug Not producing desired effect Antibiotic-resistant organism
Dosage Too Low Subtherapeutic dose Subtherapeutic warfarin (INR < 2)
Dosage Too High Toxic dose Digoxin toxicity (level > 2 ng/mL)
Adverse Drug Reaction Harmful effect from drug ACE inhibitor-induced cough
Drug Interaction Drug-drug, drug-food interaction Warfarin + NSAIDs = bleeding risk
Non-adherence Patient not taking medication Skipping doses due to cost

Mnemonic: "INDENT ADN" - Indication, Need, Drug selection, Dose, Interactions, Adverse effects, ADherence, New problem

4. Pharmacovigilance and ADR Monitoring 🔍

Pharmacovigilance is the science of detecting, assessing, understanding, and preventing adverse effects from pharmaceutical products.

Types of Adverse Drug Reactions:

  • Type A (Augmented): Predictable, dose-dependent (e.g., hypoglycemia from insulin)
  • Type B (Bizarre): Unpredictable, not dose-related (e.g., penicillin allergy)
  • Type C (Chronic): Long-term use effects (e.g., steroid-induced osteoporosis)
  • Type D (Delayed): Occurs after time delay (e.g., teratogenicity)
  • Type E (End of use): Withdrawal effects (e.g., opioid withdrawal)
  • Type F (Failure): Therapeutic failure (e.g., OCP failure with rifampicin)

Naranjo Algorithm Scoring:

Used to assess causality of ADRs:

  • Definite: Score ≥ 9
  • Probable: Score 5-8
  • Possible: Score 1-4
  • Doubtful: Score ≤ 0

Questions include: previous reports, timing, dechallenge, rechallenge, alternative causes, etc.

FDA Philippines ADR Reporting:

Healthcare professionals are required to report ADRs to the FDA Philippines Center for Drug Regulation and Research (CDRR). Use Form FDA-ADR for reporting suspected adverse reactions.

5. Drug Interactions Management 💊⚡

Clinical pharmacists must identify, prevent, and manage drug interactions to ensure patient safety.

Interaction Type Mechanism High-Yield Examples
Pharmacokinetic Affects ADME Rifampicin ↓ warfarin (CYP induction)
Pharmacodynamic Same or opposite effects Aspirin + warfarin = ↑ bleeding
Drug-Food Food affects drug Grapefruit + statins = toxicity
Drug-Disease Drug worsens condition Beta-blockers in asthma

🔥 High-Yield CYP450 Interactions:

  • CYP3A4 Inhibitors: Ketoconazole, Clarithromycin, Grapefruit juice
  • CYP3A4 Inducers: Rifampicin, Phenytoin, Carbamazepine
  • CYP2D6 Inhibitors: Fluoxetine, Paroxetine, Quinidine
  • CYP2C9 Substrates: Warfarin, Phenytoin, Losartan

6. Therapeutic Drug Monitoring (TDM) 📊

TDM involves measuring drug concentrations to optimize dosing and minimize toxicity, especially for drugs with narrow therapeutic indices.

Drug Therapeutic Range Toxic Signs Monitoring Notes
Digoxin 0.8-2.0 ng/mL Nausea, yellow vision, arrhythmias Draw 6-8 hrs post-dose
Phenytoin 10-20 mcg/mL Nystagmus, ataxia, confusion Adjust for albumin/renal function
Vancomycin Trough: 10-20 mcg/mL Nephrotoxicity, ototoxicity Draw trough before 4th dose
Aminoglycosides Peak/Trough varies Nephrotoxicity, ototoxicity Extended interval dosing preferred
Lithium 0.6-1.2 mEq/L Tremor, polyuria, seizures Draw 12 hrs post-dose
Theophylline 10-20 mcg/mL Tachycardia, seizures Many drug interactions

7. Practice Questions 📝

Question 1: Drug-Related Problem

A 65-year-old patient with diabetes and hypertension is taking metformin 500mg BID, lisinopril 10mg OD, and aspirin 80mg OD. He presents with persistent cough for 3 weeks. What is the most likely drug-related problem?

Answer: Adverse Drug Reaction - ACE inhibitor-induced cough. Lisinopril (ACE inhibitor) causes dry, persistent cough in 5-20% of patients due to bradykinin accumulation. Switch to an ARB (e.g., losartan) if cough persists.

Question 2: Therapeutic Drug Monitoring

A patient on vancomycin has a trough level of 25 mcg/mL. What is the appropriate action?

Answer: Hold the next dose and reassess. The level is supratherapeutic (>20 mcg/mL), increasing nephrotoxicity risk. Adjust the dose downward or extend the interval. Monitor serum creatinine.

Question 3: Drug Interaction

A patient on warfarin (INR stable at 2.5) is prescribed clarithromycin for respiratory infection. What should the pharmacist do?

Answer: Alert the physician about significant interaction. Clarithromycin inhibits CYP3A4 and CYP1A2, increasing warfarin levels and bleeding risk. Options: use alternative antibiotic (azithromycin is safer), reduce warfarin dose by 25-50%, or monitor INR closely (every 2-3 days).

Question 4: Naranjo Scale

A patient developed severe skin rash after starting allopurinol. The rash improved after stopping the drug. Using Naranjo algorithm, what causality category is this ADR?

Answer: Probable (Score 5-8). Points for: prior reports (+1), temporal relationship (+2), improvement after withdrawal (+1), reasonable alternative causes ruled out (+2). This is consistent with allopurinol-induced hypersensitivity syndrome.

Test Your Knowledge! 🧠

Ready ka na ba? Take the practice quiz for Clinical Pharmacy to reinforce what you just learned.

Start Practice Quiz 📝

📚 More from Pharmacy (PhLE)